$64.8 Million is the total value of AJU IB Investment Co., Ltd.'s 7 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ARCELLX INC | $19,360,000 | – | 1,380,890 | +100.0% | 29.90% | – | |
| KYMR | KYMERA THERAPEUTICS INC | $19,343,000 | -33.3% | 457,059 | 0.0% | 29.87% | -26.1% | |
| SEER | SEER INC | $12,442,000 | -33.2% | 816,375 | 0.0% | 19.21% | -25.9% | |
| RALLYBIO CORP | $5,268,000 | -26.8% | 754,678 | 0.0% | 8.14% | -18.9% | ||
| XILIO THERAPEUTICS INC | $4,721,000 | -55.8% | 667,742 | 0.0% | 7.29% | -51.0% | ||
| RAPT | RAPT THERAPEUTICS INC | $2,188,000 | -40.1% | 99,503 | 0.0% | 3.38% | -33.6% | |
| STRO | SUTRO BIOPHARMA INC | $1,439,000 | -44.7% | 175,000 | 0.0% | 2.22% | -38.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KYMERA THERAPEUTICS INC | 8 | Q3 2022 | 40.4% |
| SEER INC | 8 | Q3 2022 | 25.9% |
| RAPT THERAPEUTICS INC | 8 | Q3 2022 | 5.1% |
| SUTRO BIOPHARMA INC | 8 | Q3 2022 | 3.6% |
| ATEA PHARMACEUTICALS INC | 4 | Q3 2021 | 47.7% |
| APELLIS PHARMACEUTICALS INC | 4 | Q3 2021 | 38.8% |
| RALLYBIO CORP | 4 | Q3 2022 | 18.7% |
| XILIO THERAPEUTICS INC | 4 | Q3 2022 | 14.9% |
| CLEARSIDE BIOMEDICAL INC | 4 | Q3 2021 | 1.1% |
| MOLECULAR TEMPLATES INC | 4 | Q3 2021 | 1.0% |
View AJU IB Investment Co., Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2022-11-14 |
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-09 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-05-12 |
| 13F-HR | 2021-05-12 |
| 4 | 2017-11-13 |
View AJU IB Investment Co., Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.